Article info

PDF

Extended report
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

Authors

  1. Correspondence to Prof Philip Mease, Rheumatology Research, Swedish Medical Center, Seattle, WA 98122, USA; pmease{at}philipmease.com
View Full Text

Citation

Mease P, van der Heijde D, Landewé R, et al
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

Publication history

  • Received November 13, 2017
  • Revised January 30, 2018
  • Accepted February 19, 2018
  • First published March 17, 2018.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.